TY - JOUR
T1 - Orally desensitized mast cells form a regulatory network with Treg cells for the control of food allergy
AU - Takasato, Yoshihiro
AU - Kurashima, Yosuke
AU - Kiuchi, Masahiro
AU - Hirahara, Kiyoshi
AU - Murasaki, Sayuri
AU - Arai, Fujimi
AU - Izawa, Kumi
AU - Kaitani, Ayako
AU - Shimada, Kaoru
AU - Saito, Yukari
AU - Toyoshima, Shota
AU - Nakamura, Miho
AU - Fujisawa, Kumiko
AU - Okayama, Yoshimichi
AU - Kunisawa, Jun
AU - Kubo, Masato
AU - Takemura, Naoki
AU - Uematsu, Satoshi
AU - Akira, Shizuo
AU - Kitaura, Jiro
AU - Takahashi, Takao
AU - Nakayama, Toshinori
AU - Kiyono, Hiroshi
N1 - Funding Information:
We thank Dr. T. Kitamura (University of Tokyo) for the constructive discussions and for providing reagents; Dr. H. Suto (Atopy Research Center, Juntendo University) for providing KitW-sh/W-sh mice; and Yuta Kogure, Kaoru Shimada, Yoshinao Konuma and Daiki Yamamoto (University of Tokyo) and Masako Morimoto (Chiba University) for technical support. This work was supported by grants from The Ministry of Education, Culture, Sports, Science, and Technology for Translational Research Network Program (at the University of Tokyo) Seeds A (Y.K.), B (H.K.), and C (H.K.), and LEADER (Y.K.); the Japan Agency for Medical Research and Development for CREST (H.K.) and PRIME (20gm6010012h0004 and 20gm6210024h0001 to Y.K.); the Japan Society for the Promotion of Science for a Grant-in Aid for Scientific Research S [18H05280 to H.K.] and Scientific Research B [19H03450 to Y.K.], Young Scientists A [16H06243 to Y.K.], Challenging Exploratory Research [17K19550 and 19K22634 to Y.K.], Funds for the Promotion of Joint International Research [18KK0432 to Y.K.], Science and Technology Research Partnership for Sustainable Development [H.K.]; the Joint Research Project of the Institute of Medical Science, University of Tokyo (J.K.); the Senri Life Science Foundation [Y.K.], the Mochida Memorial Foundation for Medical and Pharmaceutical Research [Y.K.], the Takeda Science Foundation [Y.K.], the Uehara Memorial Foundation [Y.K.], the Sumitomo Foundation (Y.K.), the Naito Foundation (Y.K), the Kato Memorial Bio-Science Foundation (Y.K.), the Yakult Bio-Science Foundation, and NipponHam Foundation (Y.K.); and the Chiba University – UC San Diego Center for Mucosal Immunology, Allergy, and Vaccines (H.K.).
Publisher Copyright:
© 2020, The Author(s).
PY - 2021/5
Y1 - 2021/5
N2 - Oral immunotherapy (OIT) is an effective approach to controlling food allergy. Although the detailed molecular and cellular mechanisms of OIT are unknown currently, they must be understood to advance the treatment of allergic diseases in general. To elucidate the mechanisms of OIT, especially during the immunological transition from desensitization to allergy regulation, we generated a clinical OIT murine model and used it to examine immunological events of OIT. We found that in mice that completed OIT successfully, desensitized mast cells (MCs) showed functionally beneficial alterations, such as increased induction of regulatory cytokines and enhanced expansion of regulatory T cells. Importantly, these regulatory-T-cell-mediated inhibitions of allergic responses were dramatically decreased in mice lacking OIT-induced desensitized MC. Collectively, these findings show that the desensitization process modulates the activation of MCs, leading directly to enhanced induction of regulatory-T-cell expansion and promotion of clinical allergic unresponsiveness. Our results suggest that efficiently inducing regulatory MCs is a novel strategy for the treatment of allergic disease.
AB - Oral immunotherapy (OIT) is an effective approach to controlling food allergy. Although the detailed molecular and cellular mechanisms of OIT are unknown currently, they must be understood to advance the treatment of allergic diseases in general. To elucidate the mechanisms of OIT, especially during the immunological transition from desensitization to allergy regulation, we generated a clinical OIT murine model and used it to examine immunological events of OIT. We found that in mice that completed OIT successfully, desensitized mast cells (MCs) showed functionally beneficial alterations, such as increased induction of regulatory cytokines and enhanced expansion of regulatory T cells. Importantly, these regulatory-T-cell-mediated inhibitions of allergic responses were dramatically decreased in mice lacking OIT-induced desensitized MC. Collectively, these findings show that the desensitization process modulates the activation of MCs, leading directly to enhanced induction of regulatory-T-cell expansion and promotion of clinical allergic unresponsiveness. Our results suggest that efficiently inducing regulatory MCs is a novel strategy for the treatment of allergic disease.
UR - http://www.scopus.com/inward/record.url?scp=85097410803&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85097410803&partnerID=8YFLogxK
U2 - 10.1038/s41385-020-00358-3
DO - 10.1038/s41385-020-00358-3
M3 - Article
C2 - 33299086
AN - SCOPUS:85097410803
SN - 1933-0219
VL - 14
SP - 640
EP - 651
JO - Mucosal Immunology
JF - Mucosal Immunology
IS - 3
ER -